Related Experiment Video
Updated: Jun 25, 2026

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis
Laurent Dubuquoy1, Emmelie A Jansson, Samir Deeb
1Equipe Propre INSERM 0114 sur la Physiopathologie des Maladies Inflammatoires Intestinales, Lille, France.
Background & Aims:
The peroxisome proliferator-activated receptor gamma (PPAR gamma) has been proposed as a key inhibitor of colitis through attenuation of nuclear factor kappa B (NF-kappa B) activity. In inflammatory bowel disease, activators of NF-kappa B, including the bacterial receptor toll-like receptor (TLR)4, are elevated. We aimed to determine the role of bacteria and their signaling effects on PPAR gamma regulation during inflammatory bowel disease (IBD).
Methods:
TLR4-transfected Caco-2 cells, germ-free mice, and mice devoid of functional TLR4 (Lps(d)/Lps(d) mice) were assessed for their expression of PPAR gamma in colonic tissues in the presence or absence of bacteria. This nuclear receptor expression and the polymorphisms of gene also were assessed in patients with Crohn's disease (CD) and ulcerative colitis (UC), 2 inflammatory bowel diseases resulting from an abnormal immune response to bacterial antigens.
Results:
TLR4-transfected Caco-2 cells showed that the TLR4 signaling pathway elevated PPAR gamma expression and a PPAR gamma-dependent reporter in an I kappa kappa beta dependent fashion. Murine and human intestinal flora induced PPAR gamma expression in colonic epithelial cells of control mice. PPAR gamma expression was significantly higher in the colon of control compared with Lps(d)/Lps(d) mice. Although PPAR gamma levels appeared normal in patients with CD and controls, UC patients displayed a reduced expression of PPAR gamma confined to colonic epithelial cells, without any mutation in the PPAR gamma gene.
Conclusions:
These data showed that the commensal intestinal flora affects the expression of PPAR gamma and that PPAR gamma expression is considerably impaired in patients with UC.
Insights
Intestinal bacteria influence PPAR gamma expression, which is reduced in ulcerative colitis patients. This finding highlights the role of gut microbiota in inflammatory bowel disease pathogenesis.
Area of Science:
- Gastroenterology
- Immunology
- Microbiology
Background:
- Peroxisome proliferator-activated receptor gamma (PPAR gamma) may inhibit colitis by reducing nuclear factor kappa B (NF-kappa B) activity.
- Elevated NF-kappa B activators, such as toll-like receptor 4 (TLR4), are implicated in inflammatory bowel disease (IBD).
Purpose of the Study:
- To investigate the influence of bacteria and their signaling pathways on PPAR gamma regulation in IBD.
- To assess the role of TLR4 in PPAR gamma expression within the context of IBD.
Main Methods:
- Assessed PPAR gamma expression in TLR4-transfected Caco-2 cells, germ-free mice, and TLR4-deficient mice (Lps(d)/Lps(d)).
- Evaluated colonic PPAR gamma expression and gene polymorphisms in patients with Crohn's disease (CD) and ulcerative colitis (UC).
Main Results:
- TLR4 signaling elevated PPAR gamma expression in a NF-kappa B-dependent manner.
- Intestinal flora induced PPAR gamma expression in colonic epithelial cells of control mice.
- UC patients showed significantly reduced colonic PPAR gamma expression compared to controls and CD patients, without gene mutations.
Conclusions:
- Commensal intestinal flora significantly impacts PPAR gamma expression.
- PPAR gamma expression is notably impaired in the colonic epithelial cells of ulcerative colitis patients.
Related Concept Videos
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease

